Amarin Corp Plc (AMRN)

[heysfguy]

Kiwi, you seem to be suggesting AMRN is getting desperate to grow their market, by connecting the unimpressive scrips data and the new legal actions. I don't think they're really all that connected.

Logically, if AMRN already had label expansion, it would still make sense from them to get EPA products off the shelves. So regardless of their overall market position, it is definitely in the interest of all shareholders to get a ruling against this kind of competition.

Moreover, the fallout of this type of legal action may prove highly interesting in putting FDA on the spot. Keeping the pressure on, so to speak. Perhaps FDA isn't budging and AMRN is now forced to go through another channel to get FDA to be more favorable.

It's certainly tactical, but I wouldn't assume it's a sign of weakness.